Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension-the impact of microalbuminuria: a 13-year follow-up study

Metabolism: Clinical and Experimental

Volumn 58, Issue 3, 2009, Pages 408-415

  Solbu, Marit Dahl ^a,b   Jenssen, Trond G ^b,c   Eriksen, Bjørn O ^a,b   Toft, Ingrid ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIGEN; C REACTIVE PROTEIN; D DIMER; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; KIDNEY FUNCTION; MALE; METABOLIC DISORDER; MICROALBUMINURIA; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ADULT; AGED; ALBUMINURIA; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; ENDOTHELIUM, VASCULAR; FATTY ACIDS, NONESTERIFIED; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 59649107970     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.10.016     Document Type: Article

References (39)

1. Mogensen C.E., and Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311 (1984) 89-93
2. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310 (1984) 356-360
3. Bigazzi R., Bianchi S., Baldari D., et al. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 16 (1998) 1325-1333
4. Romundstad S., Holmen J., Hallan H., et al. Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trondelag Health Study (HUNT), Norway. Circulation 108 (2003) 2783-2789
5. Arnlov J., Evans J.C., Meigs J.B., et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112 (2005) 969-975
6. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106 (2002) 1777-1782
7. Yuyun M.F., Khaw K.T., Luben R., et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 33 (2004) 189-198
8. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
9. Marin R., Rodriguez P., Tranche S., et al. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. J Am Soc Nephrol 17 Suppl 3 (2006) S178-S188
10. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 47 (1998) 793-800
11. Jager A., Kostense P.J., Nijpels G., et al. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 41 (1998) 694-700
12. Toft I., Bonaa K.H., Eikrem J., et al. Microalbuminuria in hypertension is not a determinant of insulin resistance. Kidney Int 61 (2002) 1445-1452
13. Brantsma A.H., Bakker S.J., Hillege H.L., et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28 (2005) 2525-2530
14. Mykkanen L., Haffner S.M., Kuusisto J., et al. Microalbuminuria precedes the development of NIDDM. Diabetes 43 (1994) 552-557
15. de Zeeuw D., Parving H.H., and Henning R.H. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 17 (2006) 2100-2105
16. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32 (1989) 219-226
17. Verhave J.C., Gansevoort R.T., Hillege H.L., et al. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int 16 Suppl 92 (2004) S18-S21
18. Nosadini R., Velussi M., Brocco E., et al. Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms. Diabetes 54 (2005) 228-233
19. Toft I., Bonaa K.H., Ingebretsen O.C., et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 123 (1995) 911-918
20. Johnsen S.H., Mathiesen E.B., Joakimsen O., et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 Persons: the Tromso Study. Stroke 38 (2007) 2873-2880
21. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
22. Mitrakou A., Vuorinen-Markkola H., Raptis G., et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab 75 (1992) 379-382
23. McGuire E.A., Helderman J.H., Tobin J.D., et al. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41 (1976) 565-573
24. Levey A.S., Greene T., Kusek J.W., et al. A simplified equation to predict glomerular filtration rate from serum creatinine. (Abstract). J Am Soc Nephrol 11 (2000) 155A
25. Levey A.S., Coresh J., Greene T., et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53 (2007) 766-772
26. Franciosi M., Pellegrini F., Sacco M., et al. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clin J Am Soc Nephrol 2 (2007) 984-991
27. Chandie Shaw P.K., Berger S.P., Mallat M., et al. Central obesity is an independent risk factor for albuminuria in "non-diabetic" South Asian subjects. Diabetes Care 30 (2007) 1840-1844
28. Ferris M., Hogan S.L., Chin H., et al. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III Study. Clin J Am Soc Nephrol 2 (2007) 1207-1214
29. de Boer I.H., Astor B.C., Kramer H., et al. Lipoprotein abnormalities associated with mild impairment of kidney function in the Multi-Ethnic Study of Atherosclerosis. Clin J Am Soc Nephrol 3 (2008) 125-132
30. Shankar A., Klein R., Moss S.E., et al. The relationship between albuminuria and hypercholesterolemia. J Nephrol 17 (2004) 658-665
31. Romundstad S., Holmen J., Hallan H., et al. Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord-Trondelag Health Study (HUNT, 1995-97), Norway. J Intern Med 252 (2002) 164-172
32. Redon J., Morales-Olivas F., Galgo A., et al. Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension. J Am Soc Nephrol 17 Suppl 3 (2006) S236-S245
33. Kronborg J., Solbu M., Njolstad I., et al. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant 23 (2008) 2818-2826
34. Perticone F., Maio R., Tripepi G., et al. Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension. J Nephrol 20 Suppl 12 (2007) S56-S62
35. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
36. Hallan S., Astor B., Romundstad S., et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II Study. Arch Intern Med 167 (2007) 2490-2496
37. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
38. Schmieder R.E., Delles C., Mimran A., et al. Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes. Diabetes Care 6 (2007) 1351-1356
39. Abuissa H., Jones P.G., Marso S.P., et al. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 46 (2005) 821-826